ALDH2 and Cardiovascular Disease (2019)
- Authors:
- Autor USP: FERREIRA, JULIO CESAR BATISTA - ICB
- Unidade: ICB
- DOI: 10.1007/978-981-13-6260-6_3
- Subjects: ANATOMIA; DOENÇAS CARDIOVASCULARES; ALDEÍDOS; MITOCÔNDRIAS; METABÓLITOS; ESTRESSE OXIDATIVO; VARIAÇÃO GENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Advances in Experimental Medicine and Biology
- ISSN: 2214-8019
- Volume/Número/Paginação/Ano: p. 53–67, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CHEN, Che-Hong e FERREIRA, Julio Cesar Batista e ROSEN, Daria Mochly. ALDH2 and Cardiovascular Disease. Advances in Experimental Medicine and Biology, p. 53–67, 2019Tradução . . Disponível em: https://doi.org/10.1007/978-981-13-6260-6_3. Acesso em: 04 jun. 2024. -
APA
Chen, C. -H., Ferreira, J. C. B., & Rosen, D. M. (2019). ALDH2 and Cardiovascular Disease. Advances in Experimental Medicine and Biology, 53–67. doi:10.1007/978-981-13-6260-6_3 -
NLM
Chen C-H, Ferreira JCB, Rosen DM. ALDH2 and Cardiovascular Disease [Internet]. Advances in Experimental Medicine and Biology. 2019 ; 53–67.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-981-13-6260-6_3 -
Vancouver
Chen C-H, Ferreira JCB, Rosen DM. ALDH2 and Cardiovascular Disease [Internet]. Advances in Experimental Medicine and Biology. 2019 ; 53–67.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1007/978-981-13-6260-6_3 - In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-13C]pyruvate
- Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury
- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death
- Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities
- Mitochondrial dysfunction in degenerative diseases
- Participação da isoforma proteína quinase C 'beta' II na insuficiência cardíaca
- Nitroglycerin use in myocardial infarction patients
- New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
- Mitochondrial quality control in cardiac diseases
- Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities
Informações sobre o DOI: 10.1007/978-981-13-6260-6_3 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
